Artificial Intelligence Governance in Health Systems: Systematic Review of Frameworks and Integrative Model Proposal

• by Hassane Alami, Renata Pozelli Sabio, Elsury Johanna Pérez, Marie-Pierre Gagnon, Lyse Langlois, Jean-Louis Denis, Kathy Malas, Lysanne Rivard, Mathilde Savoldelli, Mohamed Ali Ag Ahmed, Jean-Paul Fortin

• June 8, 2026

Enhancing clinically cardiovascular machine learning model for risk prediction via sample augmentation

• by Xiaoyu Tang, Min Tang, Wu Liu, Shaoyang Cui

• June 9, 2026

FDA Expands Marstacimab Indication in Hemophilia A and B

Phase 3 BASIS and BASIS KIDS data supported the expanded indication across pediatric and inhibitor populations.

• by Kathryn Wighton

• June 8, 2026

• 3 min

Chemoimmunotherapy Linked to HNSCC Response

Higher pathologic response rates with chemoimmunotherapy versus immunotherapy alone call for phase 3 trials, but survival implications remain unknown.

• by Andrea Surnit

• June 5, 2026

• 6 min